Access to the PPM Journal and newsletters is FREE for clinicians.
Signup for PPM

All Inflammatory Arthritis Articles

with Joel M. Kremer, MD, Don L. Goldenberg, MD, and Liana Fraenkel, MD
As rheumatoid arthritis (RA) treatment continues to improve, more patients are experiencing disease remission, but even with new biologic agents, about 30% of patients do not respond well to them.
Metformin is a commonly used as a first-line agent for the treatment of type 2 diabetes mellitus. The agent acts through various mechanisms to accomplish blood glucose lowering. These mechanisms are broadly linked to effects on the cell cycle as well as signaling pathways, including m-TOR and AMPK.
Gout is a life-long, recurrent metabolic disorder considered to be type of arthritis, with both acute exacerbations and chronic joint damage and pain. Usually, the acute exacerbation of gout is associated with a rapid onset of severe pain and swelling in the joints.
The American College of Rheumatology (ACR) released its first-ever guideline on managing reproductive health in patients with rheumatic diseases, titled, 2020 Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.1
New insights into psychiatric problems associated with rheumatoid arthritis provide new thought into a potential link.
A hormone produced during pregnancy might be an effective treatment for frozen shoulder and arthrofibrosis of other joints as well.
The JAK1-selective inhibitor was found to have a solid safety profile.
A common painkiller for arthritis and joint pain has been tied to increased risk of heart problems.
There is a notable lack of detailed knowledge on pain areas in axial spondyloarthritis, and their clinical relevance is largely unknown.
Results from a survey show a need for better collaboration and greater access to information for CRD patients considering pregnancy.
How to effectively assess patients with rheumatoid arthritis or osteoarthritis, using case study examples.
With Angus B. Worthing, MD, Don L. Goldenberg, MD, and Bharat Kumar, MD, FACP
Study on arthritis trends in the US turns up some unexpected results.
Results show significant impact on signs, symptoms and radiographic progression compared to placebo.
A look at the mechanisms responsible for psoriatic arthritis as well as standards of care including new and emerging treatments.
Primary care providers need to work closely with the rheumatologist to identify and manage comorbid conditions with special attention to cardiovascular risk, depression, and osteoporosis.
Philip J. Mease, MD, and Elaine Husni, MD, MPH, explore the incidence, diagnosis, and established and emerging treatments of psoriatic arthritis, a painful autoimmune arthritis.
Learn more about polymyalgia rheumatica, the second most common form of autoimmune rheumatic disease.
Three cases illustrate the difficulties that may be seen when diagnosing, treating, and caring for patients with RA.
Does having gout increase the risk of heart failure? A team of researchers investigates this question.
Research has shown that some rare forms of gout are genetic, but is this true for all gout cases? In a new twin study, researchers investigated whether gout is mostly genetic or if environmental factors play a role, too.
To prevent further joint destruction and improve current joint and muscle capabilities in patients with inflammatory arthritis, physicians can refer patients for physical and occupational therapy.
close X